The closer

By Edyta Zielinska The closer Dr. Pablo Huertas / Steve Jackson lab / The Wellcome Trust/Cancer Research UK Gurdon Institute The paper: A. Sartori et al., “Human CtIP promotes DNA end resection,” Nature, 450:509–14, 2007. (Cited 135 times) The finding: Stephen Jackson and colleagues at the University of Cambridge, United Kingdom, showed that the protein CtIP, known to interact with tumor suppressor genes, could

Written byEdyta Zielinska
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:
A. Sartori et al., “Human CtIP promotes DNA end resection,” Nature, 450:509–14, 2007. (Cited 135 times)

The finding:
Stephen Jackson and colleagues at the University of Cambridge, United Kingdom, showed that the protein CtIP, known to interact with tumor suppressor genes, could also help repair DNA double-strand breaks by homologous recombination, which uses the duplicate, unbroken chromosome as a template. A better understanding of the repair pathway can potentially lead to new targets for cancer, characterized by a flawed repair system.

The detail: The researchers knew that CtIP binds to another protein involved in homologous repair. When they would “zap [the cells] with a laser” to create double-strand breaks, says Jackson, they’d see CtIP—bound to GFP—light up at the damage site. This occurred only in S phase or G2, when the cell’s DNA was doubled. If zapped in G1, when the cell has only one copy of its ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies